Literature DB >> 33627772

Atlantic DIP: is weight gain less than that recommended by IOM safe in obese women with gestational diabetes mellitus?

Delia Bogdanet1,2, Mohamad Mustafa3, Aftab Khattak3, Paula M O' Shea4,3, Fidelma P Dunne4,3.   

Abstract

BACKGROUND/
OBJECTIVES: The Institute of Medicine (IOM) recommends gestational weight gain (GWG) of 5-9 kg in women with a body mass index (BMI) ≥ 30 kg/m2. Debate continues as to whether GWG less than that recommended is safe in women with gestational diabetes mellitus (GDM). The study objective was to examine maternal and infant outcomes for obese women with GDM who lost weight or gained 0-5 kg during pregnancy. SUBJECTS/
METHODS: A 7-year retrospective cohort study of pregnancy outcomes for obese women with GDM recorded in the Atlantic Diabetes in Pregnancy database was conducted. We examined pregnancy outcomes for mothers with GDM and a BMI ≥ 30 who either lost weight or gained 0-5 kg (Group 1, n = 237) and women who gained 5-9 kg (Group 2, n = 77). We further divided groups 1 and 2 into women treated by diet only (GDM-D) (n = 120) and those requiring additional treatment with insulin (GDM-I) (n = 194).
RESULTS: GDM-D women in Group 1 were more likely to deliver earlier (38.9 vs 39.8 weeks, p < 0.01), to develop pregnancy induced hypertension (PIH) (15.4% v 0%; p = 0.02) or have a post-partum haemorrhage (PPH) (13.2% vs 0, p = 0.03) compared to women in Group 2. Rates of prematurity were higher in group 1 vs 2 (14.3% vs 0%, p = 0.03). However, further logistic regression analysis adjusted for smoking status, family history of diabetes, ethnicity and age determined no significant difference in maternal or infant outcomes for women in Group 1 compared to those in Group 2.
CONCLUSION: In our population, weight gain less than IOM guideline appears safe and is not associated with any further increase in adverse outcomes. However, validation through a prospective study with a larger obese GDM cohort is required before the findings presented here could be recommended for routine clinical use.

Entities:  

Mesh:

Year:  2021        PMID: 33627772     DOI: 10.1038/s41366-021-00769-7

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  2 in total

1.  Weight gain in pregnancy: does the Institute of Medicine have it right?

Authors:  Yen N Truong; Lynn M Yee; Aaron B Caughey; Yvonne W Cheng
Journal:  Am J Obstet Gynecol       Date:  2015-03       Impact factor: 8.661

2.  Association between foetal growth and different maternal metabolic characteristics in women with gestational diabetes mellitus.

Authors:  B Krstevska; V Velkoska Nakova; G Adamova; S Simeonova; Ch Dimitrovski; V Livrinova; V Serafimoski
Journal:  Prilozi       Date:  2009-12
  2 in total
  2 in total

1.  Gestational Diabetes Mellitus as an Effect Modifier of the Association of Gestational Weight Gain with Perinatal Outcomes: A Prospective Cohort Study in China.

Authors:  Zhi-Hao Cheng; Yu-Mei Wei; Hong-Tian Li; Hong-Zhao Yu; Jian-Meng Liu; Yu-Bo Zhou
Journal:  Int J Environ Res Public Health       Date:  2022-05-05       Impact factor: 4.614

2.  Sex-specific mediating effect of gestational weight gain between pre-pregnancy body mass index and gestational diabetes mellitus.

Authors:  Shuang Zhang; Jingyu Wang; Fang Xu; Juhong Yang; Yongzhang Qin; Junhong Leng; Nan Li; Jia Guo; Xiaochen Li; Zhong'ai Gao; Xiaofang Shen; Hui Gao; Baocheng Chang; Hong Zhu
Journal:  Nutr Diabetes       Date:  2022-04-25       Impact factor: 4.725

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.